Sale!

CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies germline mutations in the CBL gene associated with Juvenile Myelomonocytic Leukemia (JMML). Using Next-Generation Sequencing (NGS) technology, this test provides precise detection of genetic abnormalities that predispose individuals to this rare childhood leukemia. The test is crucial for early diagnosis, family risk assessment, and personalized treatment planning. At just $500 USD, this advanced genetic screening offers invaluable insights for patients with suspected JMML or family history of the condition. Results are typically available within 3-4 weeks from blood or DNA samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test

Understanding CBL Gene Juvenile Myelomonocytic Leukemia Testing

The CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test represents a breakthrough in pediatric oncology diagnostics. This advanced genetic screening utilizes Next-Generation Sequencing (NGS) technology to detect germline mutations in the CBL gene, which are directly associated with Juvenile Myelomonocytic Leukemia (JMML) – a rare and aggressive form of childhood leukemia affecting the bone marrow and blood cells.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets:

  • Germline mutations in the CBL (Casitas B-lineage lymphoma) gene
  • Pathogenic variants affecting the ubiquitin ligase function of CBL protein
  • Mutations that disrupt normal cellular signaling pathways
  • Genetic abnormalities leading to uncontrolled myeloid cell proliferation
  • Inherited predisposition to Juvenile Myelomonocytic Leukemia

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with:

  • Children with unexplained hepatosplenomegaly (enlarged liver and spleen)
  • Patients showing signs of monocytosis and myeloid dysplasia
  • Individuals with family history of Juvenile Myelomonocytic Leukemia
  • Children exhibiting symptoms of bone marrow failure
  • Patients with Noonan syndrome-like features
  • Individuals with suspected RASopathies or related genetic disorders

Clinical Symptoms and Indications

Common clinical presentations that warrant CBL gene testing include:

  • Persistent fever and recurrent infections
  • Easy bruising or bleeding tendencies
  • Pallor and fatigue due to anemia
  • Lymphadenopathy (swollen lymph nodes)
  • Skin rashes or abnormal skin findings
  • Developmental delays in some cases

Benefits of CBL Gene Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Early Diagnosis: Enables prompt identification of JMML before advanced progression
  • Family Risk Assessment: Identifies inherited genetic predisposition in family members
  • Personalized Treatment: Guides targeted therapeutic approaches based on genetic profile
  • Prognostic Information: Provides insights into disease course and potential outcomes
  • Reproductive Planning: Assists families in making informed decisions about future pregnancies
  • Clinical Trial Eligibility: May qualify patients for specialized treatment protocols

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and oncologists:

  • Positive Result: Indicates presence of CBL germline mutation, confirming genetic predisposition to JMML
  • Negative Result: Suggests absence of detectable CBL mutations, though other genetic factors may be involved
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical implications requiring further evaluation
  • Comprehensive Report: Includes detailed analysis, clinical correlations, and management recommendations

Test Pricing and Information

Test Feature Details
Test Name CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history of the patient
  • Genetic counseling session to create family pedigree chart
  • Documentation of family members affected by JMML or related conditions
  • Referral from qualified healthcare provider

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, Milwaukee, Albuquerque, Tucson, Fresno, Sacramento, and many more.

Take Action Today

Don’t wait to get the answers you need for your child’s health. Our dedicated team of genetic specialists and oncology experts are ready to provide comprehensive care and support throughout your testing journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your CBL Gene Juvenile Myelomonocytic Leukemia NGS Genetic DNA Test and take the first step toward accurate diagnosis and personalized treatment planning.

Early detection through genetic testing can make a significant difference in treatment outcomes and quality of life. Trust our expertise in genetic oncology to provide the answers and guidance your family deserves.